ask="6.65"
ask_size="300"
average_daily_volume="32473"
bid="5.97"
bid_size="2000"
book_value="1.81"
change="+0.04"
change_from_200_day_moving_average="-0.76"
change_from_50_day_moving_average="-0.11"
change_from_52_week_high="-4.33"
change_From_52_week_low="0.48"
change_in_percent="+0.65%"
close="6.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.86"
ebitda="-9.95M"
eps_estimate_current_year="-0.62"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-1.01"
ex_dividend_date="N/A"
float_shares="8664000"
high="6.18"
high_52_weeks="10.51"
last_trade_date="2/6/2017"
last_trade_price="6.18"
last_trade_size="100"
last_trade_time="3:59pm"
low="5.92"
low_52_weeks="5.70"
market_capitalization="82.09M"
moving_average_200_day="6.94"
moving_average_50_day="6.29"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.00"
open="6.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-10.90%"
percent_change_from_50_day_moving_average="-1.73%"
percent_change_from_52_week_high="-41.20%"
percent_change_from_52_week_low="+8.42%"
previous_close="6.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.40"
price_per_sales="65.19"
revenue="1.25M"
shares_outstanding="13283000"
short_ratio="8.25"
stock_exchange="NCM"
symbol="ORMP"
volume="35191"
weeks_range_52="5.70 - 10.51"
